pravastatin has been researched along with lathosterol in 18 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 7 (38.89) | 18.2507 |
| 2000's | 8 (44.44) | 29.6817 |
| 2010's | 3 (16.67) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Miettinen, TA; Vanhanen, H | 1 |
| Kesäniemi, YA; Miettinen, TA; Vanhanen, H | 1 |
| Angelin, B; Berglund, L; Dallner, G; Elmberger, PG; Eriksson, M; Kalén, A; Lund, E; Reihnér, E | 1 |
| Fujiyama, J; Kuriyama, M; Osame, M; Tokimura, Y; Utatsu, Y | 1 |
| Colette, C; Crastes De Paulet, A; Descomps, B; Farnier, M; Feillet, C; Monnier, LH; Percheron, C | 1 |
| Einarsson, K; Eriksson, M; Hillebrant, CG; Nyberg, B | 1 |
| Braesen, JH; Gebhardt, A; Harsch, M; Lang, G; Löser, R; Niendorf, A; Reymann, A; Schliack, M | 1 |
| Aldaghlas, TA; Berthold, HK; Holleran, AL; Kelleher, JK; Lindenthal, B; Sudhop, T; Von Bergmann, K | 1 |
| Björkhem, I; Einarsson, C; Gustafsson, U; Hillebrant, CG; Nyberg, B; Rudling, M; Sahlin, S | 1 |
| Clarenbach, JJ; Dotti, MT; Federico, A; Kelleher, JK; Lindenthal, B; von Bergmann, K | 1 |
| Backman, JT; Eichelbaum, M; Hofmann, U; Kivistö, KT; Lütjohann, D; Neuvonen, PJ; Niemi, M; Schwab, M; von Bergmann, K | 1 |
| Janatuinen, T; Knuuti, J; Laaksonen, R; Lehtimäki, T; Lütjohann, D; Thelen, KM; Vesalainen, R; von Bergmann, K | 1 |
| Antikainen, M; Gylling, H; Hedman, M; Ketomäki, A; Miettinen, TA | 1 |
| Gerloff, T; Johne, A; Lütjohann, D; Mwinyi, J; Roots, I; Schaefer, M; Sudhop, T; von Bergmann, K | 1 |
| Arnold, KA; Eichelbaum, M; Hofmann, U; Igel, M; Kivistö, KT; Lütjohann, D; Niemi, M; Schwab, M; von Bergmann, K | 1 |
| Buckley, BM; Ford, I; Jukema, JW; Lichtenstein, AH; Matthan, NR; Packard, C; Resteghini, N; Robertson, M; Schaefer, EJ; Shepherd, J | 1 |
| Berthold, HK; Gouni-Berthold, I; Sudhop, T; von Bergmann, K | 1 |
| Fukumoto, Y; Miura, M; Nochioka, K; Shiba, N; Shimokawa, H; Tanaka, S; Zhulanqiqige, do E | 1 |
8 trial(s) available for pravastatin and lathosterol
| Article | Year |
|---|---|
Comparative effects of simvastatin and pravastatin on cholesterol synthesis in patients with primary hypercholesterolemia.
Topics: Adolescent; Adult; Aged; Anticholesteremic Agents; Apolipoproteins; Cholesterol; Cholesterol, HDL; Cholesterol, LDL; Cross-Over Studies; Double-Blind Method; Enzyme Inhibitors; Female; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Hyperlipoproteinemia Type II; Liver; Lovastatin; Male; Mevalonic Acid; Middle Aged; Pravastatin; Simvastatin; Treatment Outcome; Triglycerides | 1995 |
Effects of combined treatment with pravastatin and ursodeoxycholic acid on hepatic cholesterol metabolism.
Topics: Adult; Aged; Anticholesteremic Agents; Bile; Case-Control Studies; Cholagogues and Choleretics; Cholelithiasis; Cholesterol; Cholesterol, LDL; Drug Therapy, Combination; Female; Humans; Male; Middle Aged; Pravastatin; Receptors, LDL; RNA, Messenger; Ursodeoxycholic Acid | 2002 |
Effect of pravastatin on plasma sterols and oxysterols in men.
Topics: Adult; Brain; Cholesterol; Humans; Hydroxycholesterols; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Male; Pravastatin; Sterols | 2006 |
Serum noncholesterol sterols in children with heterozygous familial hypercholesterolemia undergoing pravastatin therapy.
Topics: Adolescent; Anticholesteremic Agents; Child; Cholestanol; Cholesterol; Desmosterol; Female; Heterozygote; Humans; Hyperlipoproteinemia Type II; Male; Phytosterols; Pravastatin; Sitosterols; Triglycerides | 2006 |
Impact of the SLCO1B1 polymorphism on the pharmacokinetics and lipid-lowering efficacy of multiple-dose pravastatin.
Topics: Adult; Area Under Curve; Cholesterol; Cholesterol, LDL; Half-Life; Haplotypes; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Liver-Specific Organic Anion Transporter 1; Organic Anion Transporters; Pharmacogenetics; Polymorphism, Genetic; Pravastatin; Prospective Studies | 2006 |
Cholesterol absorption and synthesis markers in individuals with and without a CHD event during pravastatin therapy: insights from the PROSPER trial.
Topics: Aged; Aged, 80 and over; Cholesterol; Cholesterol, HDL; Cholesterol, LDL; Coronary Disease; Desmosterol; Female; Homeostasis; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Male; Phytosterols; Pravastatin; Sitosterols; Triglycerides | 2010 |
Lifibrol as a model compound for a novel lipid-lowering mechanism of action.
Topics: Adult; Anticholesteremic Agents; Apolipoprotein B-100; Butanols; Cholesterol; Cholesterol, HDL; Cholesterol, LDL; Cholesterol, VLDL; Double-Blind Method; Humans; Hydroxybenzoates; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Hypercholesterolemia; Lipids; Lipoproteins, LDL; Male; Pravastatin; Triglycerides; Young Adult | 2010 |
Ezetimibe improves endothelial function and inhibits Rho-kinase activity associated with inhibition of cholesterol absorption in humans.
Topics: Adult; Anticholesteremic Agents; Azetidines; Cholestanol; Cholesterol; Cross-Sectional Studies; Endothelium, Vascular; Ezetimibe; Female; Gene Expression Regulation, Enzymologic; Humans; Intestinal Absorption; Leukocytes; Male; Pravastatin; rho-Associated Kinases; Up-Regulation | 2012 |
10 other study(ies) available for pravastatin and lathosterol
| Article | Year |
|---|---|
Pravastatin and lovastatin similarly reduce serum cholesterol and its precursor levels in familial hypercholesterolaemia.
Topics: Adult; Aged; Cholesterol; Cholesterol, LDL; Desmosterol; Female; Humans; Hyperlipoproteinemia Type II; Isomerism; Lovastatin; Male; Middle Aged; Phytosterols; Pravastatin; Sitosterols; Triglycerides | 1992 |
Pravastatin lowers serum cholesterol, cholesterol-precursor sterols, fecal steroids, and cholesterol absorption in man.
Topics: Adult; Cholesterol; Feces; Female; Humans; Hyperlipoproteinemia Type II; Ileum; Intestinal Absorption; Male; Middle Aged; Pravastatin; Steroids; Sterols | 1992 |
Effects of pravastatin and cholestyramine on products of the mevalonate pathway in familial hypercholesterolemia.
Topics: Adult; Aged; Cholesterol; Cholestyramine Resin; Dolichols; Drug Therapy, Combination; Female; Humans; Hydroxymethylglutaryl CoA Reductases; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Hyperlipoproteinemia Type II; Male; Mevalonic Acid; Middle Aged; Pravastatin; Ubiquinone | 1991 |
Treatment of cerebrotendinous xanthomatosis: effects of chenodeoxycholic acid, pravastatin, and combined use.
Topics: Adult; Apolipoproteins; Brain Diseases; Chenodeoxycholic Acid; Cholestanol; Cholesterol; Drug Therapy, Combination; Electrophysiology; Humans; Lipids; Lipoproteins; Male; Middle Aged; Muscular Diseases; Phytosterols; Pravastatin; Tendons; Xanthomatosis | 1994 |
Changes in biliary lipid output after interruption of pravastatin treatment in humans.
Topics: Acyl Coenzyme A; Adult; Aged; Aged, 80 and over; Anticholesteremic Agents; Bile Acids and Salts; Cholesterol; Female; Humans; Isomerism; Lipoproteins; Liver; Male; Middle Aged; Pravastatin; Triglycerides | 1996 |
Effects of pravastatin on cholesterol metabolism of cholesterol-fed heterozygous WHHL rabbits.
Topics: Animals; Anticholesteremic Agents; Cholesterol; Cholesterol, Dietary; Heterozygote; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Hyperlipoproteinemia Type II; Immunohistochemistry; Intestinal Absorption; Liver; Phytosterols; Polymerase Chain Reaction; Pravastatin; Rabbits; Receptors, LDL; RNA, Messenger | 1998 |
Isotopomer spectral analysis of intermediates of cholesterol synthesis in human subjects and hepatic cells.
Topics: Acetates; Acetyl Coenzyme A; Carbon Isotopes; Carcinoma, Hepatocellular; Cholesterol; Duodenum; Gas Chromatography-Mass Spectrometry; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Isotope Labeling; Kinetics; Liver; Liver Neoplasms; Models, Biological; Pravastatin; Simvastatin; Tumor Cells, Cultured | 2002 |
Isotopomer spectral analysis of intermediates of cholesterol synthesis in patients with cerebrotendinous xanthomatosis.
Topics: Adult; Bile; Bile Acids and Salts; Carbon Isotopes; Chenodeoxycholic Acid; Cholestanol; Cholestanols; Cholesterol; Female; Gas Chromatography-Mass Spectrometry; Humans; Isotope Labeling; Lanosterol; Male; Middle Aged; Pravastatin; Sterols; Xanthomatosis, Cerebrotendinous | 2005 |
Acute effects of pravastatin on cholesterol synthesis are associated with SLCO1B1 (encoding OATP1B1) haplotype *17.
Topics: Anticholesteremic Agents; Cholesterol; Female; Haplotypes; Humans; Liver-Specific Organic Anion Transporter 1; Male; Organic Anion Transporters; Polymorphism, Single Nucleotide; Pravastatin | 2005 |
Influence of the SLCO1B1*1b and *5 haplotypes on pravastatin's cholesterol lowering capabilities and basal sterol serum levels.
Topics: Adult; Anticholesteremic Agents; Cholesterol; Haplotypes; Humans; Liver-Specific Organic Anion Transporter 1; Male; Middle Aged; Organic Anion Transporters; Phytosterols; Pravastatin | 2006 |